Reata Pharmaceuticals (RETA) PT Raised to $85 at Baird
Tweet
Share
E-mailGet Alerts RETA Hot Sheet
Price: $172.36 --0%
Rating Summary:
6 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
6 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
Baird analyst Brian Skorney raised the price target on Reata Pharmaceuticals (NASDAQ: RETA) to $85.00 (from $40.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Kepler Cheuvreux Upgrades Entain PLC (ENT:LN) (GMVHF) to Buy
- Comstock Resources (CRK) PT Raised to $20 at Mizuho
- Petroleo Brasileiro SA (PETR4:BZ) (PBR) PT Raised to R$58.50 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
